SYRE vs UPS · $7.60B cap vs P/E 15, rev $88.66B
Spyre Therapeutics Inc. (SYRE) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported SYRE revenue for 2024-12-31 was $0. Net income was -$208.0M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. SYRE currently screens at market cap $7.60B.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
SYRE currently screens at market cap $7.60B. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the SYRE and UPS stock pages for the full models.
Not investment advice.